Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany

British Journal of Cancer

Volumn 97, Issue 11, 2007, Pages 1486-1492

  Hoffmeister, M ^a   Raum, E ^a   Winter, J ^b   Chang Claude, J ^a   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Urologische Abteilung   (Germany)

Author keywords

Body mass; Colorectal cancer; Hormone replacement therapy; Postmenopausal; Risk

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GERMANY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GERMANY; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RISK FACTORS;

EID: 36448938732     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604066     Document Type: Article

References (38)

1. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, Schatzkin A (2007) Body mass and colorectal cancer risk in the NIH - AARP cohort. Am J Epidemiol 166: 36-45, doi:10.1093/aje/kwm049
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712
3. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D, Elliman J, Harris CL (2001) Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat 6: 357-363
4. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D, Reeves G, English R, Taylor S, Elliman J, Lole Harris C (2002) Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 4: R1
5. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427
6. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91: 421-430
7. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2006) Does a negative screening colonoscopy ever need to be repeated? Gut 55: 1145-1150
8. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007a) Case- control study supports extension of surveillance interval after colonoscopic polypectomy to at least 5 yr. Am J Gastroenterol 102: 1739-1744, doi:10.1111/j.1572-0241.2007.01231.x
9. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007b) Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev 16: 494-499
10. Bromley SE, de Vries CS, Farmer RD (2004) Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database. BJOG 111: 369-376
11. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591
12. Calle EE, Miracle-McMahill HL, Thun MJ, Heath Jr CW (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87: 517-523
13. Casey VA, Dwyer JT, Berkey CS, Coleman KA, Gardner J, Valadian I (1991) Long-term memory of body weight and past weight satisfaction: a longitudinal follow-up study. Am J Clin Nutr 53: 1493-1498
14. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350: 991-1004
15. Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L (1998) Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1: 18-25
16. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD (1995) Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 85: 1128-1132
17. Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55: 285-291
18. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN (1990) Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 131: 815-825
19. Greiser E (2003) Gutachten zur Anwendung der postmenopausalen Hormontherapie in Deutschland und Vorschläge zur Senkung der Anwendungshäufigkeit. Bremen: Bremer Institut für Präventionsforschung und Sozialmedizin (BIPS)
20. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128: 705-712
21. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106: 574-582
22. Hersh AL, Stefanick ML, Stafford RS (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291: 47-53
23. Hoffmeister M, Chang-Claude J, Brenner H (2007) Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 166: 130-136
24. Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, Chow WH (2006) Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer 42: 84-90
25. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288: 58-66
26. Jain MG, Rohan TE, Howe GR (1999) Agreement of self-reported use of menopausal hormone replacement therapy with physician reports. Epidemiology 10: 260-263
27. La Vecchia C, Gallus S, Fernandez E (2005) Hormone replacement therapy and colorectal cancer: an update. J Br Menopause Soc 11: 166-172
28. Lin J, Zhang SM, Cook NR, Rexrode KM, Lee IM, Buring JE (2004) Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 15: 581-589
29. Löwel H, Heier M, Schneider A, Gösele U, Meisinger C (2003) Hormontherapie (II): Vergleiche sind zulässig. Ergebnisse aus dem KORA-Survey 2000. Dtsch Arztebl 100: A2561-A2562
30. Nanda K, Bastian LA, Hasselblad V, Simel DL (1999) Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93: 880-888
31. Paganini-Hill A (1999) Estrogen replacement therapy and colorectal cancer risk in elderly women. Dis Colon Rectum 42: 1300-1305
32. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by US adults. Epidemiology 6: 61-66
33. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, Linseisen J, Becker N, Trichopoulou A, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Van Guelpen B, Palmqvist R, Berglund G, Gonzalez CA, Dorronsoro M, Barricarte A, Navarro C, Martinez C, Quiros JR, Roddam A, Allen N, Bingham S, Khaw KT, Ferrari P, Kaaks R, Slimani N, Riboli E (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98: 920-931
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
35. Seifert-Klauss V, Schumm-Draeger PM (2003) Hormontherapie um die Menopause. Ein aktueller Blick. Der Internist 44: 1500-1507
36. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14: 75-84
37. Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni Jr JF (1997) A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 8: 130-138
38. Wang Y, Jacobs EJ, Teras LR, Pavluck AL, Rodriguez C, Thun MJ, Calle EE (2007) Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women. Cancer Causes Control 18: 793-799